| Isoindolinone inhibitors of the murine double minute 2 (MDM2)-p53 protein− protein interaction: structure− activity studies leading to improved potency IR Hardcastle, J Liu, E Valeur, A Watson, SU Ahmed, TJ Blackburn, ... Journal of medicinal chemistry 54 (5), 1233-1243, 2011 | 161 | 2011 |
| T lymphocytes and fractalkine contribute to myocardial ischemia/reperfusion injury in patients SE Boag, R Das, EV Shmeleva, A Bagnall, M Egred, N Howard, ... The Journal of clinical investigation 125 (8), 3063-3076, 2015 | 153 | 2015 |
| Melanoma-derived gangliosides impair migratory and antigen-presenting function of human epidermal Langerhans cells and induce their apoptosis K Bennaceur, I Popa, J Portoukalian, O Berthier-Vergnes, ... International immunology 18 (6), 879-886, 2006 | 74 | 2006 |
| Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon? D Kavanagh, IY Pappworth, H Anderson, CM Hayes, I Moore, EM Hunze, ... Clinical Journal of the American Society of Nephrology 7 (3), 417-426, 2012 | 73 | 2012 |
| Dendritic cells dysfunction in tumour environment K Bennaceur, J Chapman, L Brikci-Nigassa, K Sanhadji, J Touraine, ... Cancer letters 272 (2), 186-196, 2008 | 71 | 2008 |
| MDM2-p53 protein–protein interaction inhibitors: A-ring substituted isoindolinones AF Watson, J Liu, K Bennaceur, CJ Drummond, JA Endicott, BT Golding, ... Bioorganic & medicinal chemistry letters 21 (19), 5916-5919, 2011 | 62 | 2011 |
| Different mechanisms are involved in apoptosis induced by melanoma gangliosides on human monocyte-derived dendritic cells K Bennaceur, I Popa, JA Chapman, C Migdal, J Péguet-Navarro, ... Glycobiology 19 (6), 576-582, 2009 | 48 | 2009 |
| Atorvastatin induces T cell proliferation by a telomerase reverse transcriptase (TERT) mediated mechanism K Bennaceur, M Atwill, N Al Zhrany, J Hoffmann, B Keavney, D Breault, ... Atherosclerosis 236 (2), 312-320, 2014 | 46 | 2014 |
| Telomerase mediates lymphocyte proliferation but not the atherosclerosis-suppressive potential of regulatory T-cells GD Richardson, A Sage, K Bennaceur, N Al Zhrany, J Coelho-Lima, ... Arteriosclerosis, thrombosis, and vascular biology 38 (6), 1283-1296, 2018 | 31 | 2018 |
| TP53 mutant MDM2-amplified cell lines selected for resistance to MDM2-p53 binding antagonists retain sensitivity to ionizing radiation CJ Drummond, A Esfandiari, J Liu, X Lu, C Hutton, J Jackson, ... Oncotarget 7 (29), 46203, 2016 | 20 | 2016 |
| Telomerase activation to reverse immunosenescence in elderly patients with acute coronary syndrome: protocol for a randomized pilot trial R Maier, B Bawamia, K Bennaceur, S Dunn, L Marsay, R Amoah, A Kasim, ... JMIR Research Protocols 9 (9), e19456, 2020 | 17 | 2020 |
| Autoantibodies to CD59, CD55, CD46 or CD35 are not associated with atypical haemolytic uraemic syndrome (aHUS) R Watson, E Wearmouth, AC McLoughlin, A Jackson, S Ward, P Bertram, ... Molecular immunology 63 (2), 287-296, 2015 | 16 | 2015 |
| Differences in immune responses between CMV‐seronegative and‐seropositive patients with myocardial ischemia and reperfusion EV Shmeleva, SE Boag, S Murali, K Bennaceur, R Das, M Egred, I Purcell, ... Immunity, inflammation and disease 3 (2), 56-70, 2015 | 15 | 2015 |
| The Fractalkine Receptor CX3CR1 Links Lymphocyte Kinetics in CMV-Seropositive Patients and Acute Myocardial Infarction With Adverse Left Ventricular … L Spray, C Park, S Cormack, A Mohammed, P Panahi, S Boag, ... Frontiers in Immunology 12, 605857, 2021 | 14 | 2021 |
| Studies of compounds that enhance sphingolipid metabolism in human keratinocytes1 I Popa, K Bennaceur, N Abdul‐Malak, E Perrier, D Schmitt, J Portoukalian International journal of cosmetic science 28 (1), 53-59, 2006 | 10 | 2006 |
| Role of CMV-serostatus and CX3CR1 on lymphocyte kinetics and left ventricular remodelling in patients with acute myocardial infarction L Spray, C Park, S Cormack, A Mohammad, P Panahi, S Boag, ... European Heart Journal 41 (Supplement_2), ehaa946. 1289, 2020 | | 2020 |
| Telomerase Mediates Lymphocyte Proliferation but Not the Atherosclerosis-Suppressive Potential of Regulatory T-Cells G Richardson, A Sage, K Bennaceur, N Al Zhrany, J Coelho-Lima, ... Arteriosclerosis, Thrombosis, and Vascular Biology 38 (4), 2018 | | 2018 |
| Effect of CMV-seropositivity on acute outcome of acute myocardial infarction E Shmeleva, S Murali, K Bennaceur, S Todryk, I Spiridopoulos | | 2014 |
| MCP (CD46) autoantibodies are associated with atypical hemolytic uremic syndrome K Bennaceur, EM Hunze, MK Liszewski, P Bertram, SJ Staniforth, L Strain, ... XXIV International Complement Workshop, 2012 | | 2012 |
| Abstract A154: Mechanisms of cellular resistance to the growth inhibitory and cytotoxic effects of MDM2‐p53 binding antagonists J Liu, X Lu, C Drummond, C Hutton, J Jackson, K Bennaceur, D Newell, ... Molecular Cancer Therapeutics 8 (12_Supplement), A154-A154, 2009 | | 2009 |
